BackScancell Holdings plc Overview
Scancell Holdings plc

Scancell Holdings plc Return on Equity

Scancell Holdings plc (SCNLF) has a ROE of 155.12%, above the Healthcare sector average of 13.1%.

Get informed when a big investor buys or sells

+ Follow

ROE

155.12%

Return on Equity

155.12%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Scancell Holdings plc (SCNLF) FAQ

The latest ROE for SCNLF is 155.12%. That is above the Healthcare sector average of 13.1%. Investors often review this figure alongside Scancell Holdings plc's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, SCNLF currently prints 155.12% for ROE, while the sector average sits near 13.1%. That is roughly 1083.8% above the sector mean. Large gaps often invite a closer look at Scancell Holdings plc's growth, margins, and balance sheet.

Return on Equity shows how effectively Scancell Holdings plc converts resources into returns. At 155.12%, SCNLF may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SCNLF's ROE (155.12%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Scancell Holdings plc's ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.

Questions & Answers